• NN1218 – 4113

A randomized, double-blind, active controlled, treat-to-target, parallel group trial comparing efficacy and safety of fast-acting Insulin Aspart compared to NovoRapidĀ® both in combination with Insulin Degludec with or without Metformin in adults with Type 2 Diabetes (onsetĀ® 9).

If you would like additional information regarding this trial please visit the website below or contact researchopportunities@prairieresearch.com

https://clinicaltrials.gov/ct2/show/NCT03268005?cond=comparing+efficacy+and+safety+of+fast-acting+Insulin+Aspart+compared+to+NovoRapid%C2%AE&rank=1

 

  • EFC 14838

A Randomized, Double blind, Double-dummy, Active and Placebo controlled, Parallel group, Multicenter Study to Evaluate the Efficacy and Safety of Sotagliflozin compared to Glimepiride or Placebo Added to Metformin in Patients with Type 2 Diabetes who have Inadequate Glycemic Control with Metformin Monotherapy

If you would like additional information regarding this trial please visit the website below or contact researchopportunities@prairieresearch.com

https://clinicaltrials.gov/ct2/show/NCT03332771?cond=Evaluate+the+Efficacy+and+Safety+of+Sotagliflozin+compared+to+Glimepiride+or+Placebo+Added+to+Metformin&rank=1

Coming Soon

  • EFC 14875_SCORED

A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Demonstrate the Effects of Sotagliflozin on Cardiovascular and Renal Events in Patients with Type 2 Diabetes, Cardiovascular Risk Factors and Moderately Impaired Renal Function

If you would like additional information regarding this trial please visit the website below or contact researchopportunities@prairieresearch.com

https://clinicaltrials.gov/ct2/show/NCT03315143?cond=Demonstrate+the+Effects+of+Sotagliflozin+on+Cardiovascular+and+Renal+Events+in+Patients+with+Type+2+Diabetes&rank=1

 

  • Mylan 3004

A Randomized, Multi-center, Double-Blind, Parallel-Group Clinical Study Comparing the Efficacy and Safety of MYL-1501D Produced by Two Manufacturing Processes in Type 1 Diabetes Mellitus Patients